Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Vicore Pharma: Phase II in SSc Patients on Track

2020-08-25

11:43

LS

Ludvig Svensson

Redeye gives a brief comment to today’s news that Vicore has resumed recruitment to its Phase II trial with C21 in patients with systemic sclerosis (SSc).

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers